Drugs / TA-CD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00965263 | Mar 2003 → Jul 2009 | cocaine dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TA-CD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00965263 ↗ |
| Modality | Vaccine | “a cocaine vaccine (TA-CD) produces selective anticocaine antibodies” PMID 19846066 ↗ Jan 2010 |
| Route | Intramuscular | “TA-CD (82,360 μg; IM) were administered at weeks 1, 3, 5 and 9.” NCT00965263 ↗ |